Collonges sous Saleve, France

Greg Elson

USPTO Granted Patents = 36 

 

 

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 342(Granted Patents)


Location History:

  • Collenges sous Saleve, FR (2013)
  • Collonges sous Saleve, FR (2007 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Greg Elson in Monoclonal Antibody Development

Introduction

Greg Elson is a prominent inventor and researcher based in Collonges sous Saleve, France. With a remarkable portfolio of 36 patents, his work primarily focuses on the development of monoclonal antibodies aimed at therapeutic, diagnostic, and prophylactic applications. His innovative contributions have had a significant impact on biomedical research and healthcare.

Latest Patents

Among Greg Elson's latest patents are two pivotal inventions:

1. **Anti-IL-6/IL-6R antibodies and methods of use thereof** - This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The methods associated with this patent highlight these monoclonal antibodies' potential use as therapeutic, diagnostic, and prophylactic agents.

2. **Anti-TLR4 antibodies and uses thereof** - This patent discloses antibodies that specifically bind to Toll-like Receptor 4 (TLR-4). It also includes methods of using these anti-TLR4 antibodies as therapeutics and diagnostic tools, showcasing their importance in treating various conditions.

Career Highlights

Greg Elson's career has been distinguished by his tenure at notable companies in the biotechnology sector, including Novimmune SA and Novimmunie S.A. His work at these organizations has contributed to advancements in the development of monoclonal antibodies, establishing him as a leader in the field.

Collaborations

Throughout his career, Greg has collaborated with esteemed colleagues, including Olivier Leger and Marie Kosco-Vilbois. These collaborations have resulted in the sharing of knowledge and expertise, further enhancing the innovations and inventions that stem from his research endeavors.

Conclusion

Greg Elson's innovative spirit and dedication to research have undeniably enriched the field of biotechnology. With numerous patents to his name, his work on monoclonal antibodies not only advances scientific understanding but also paves the way for new therapeutic solutions. As the landscape of biomedical research continues to evolve, Elson's contributions will remain integral to future innovations in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…